RNA polymerase II Elongation Complex: Structure and Function
RNA polymerase II Elongation Complex: Structure and Function
批准号:
8527791
负责人:
Daniel Reines
金额:
$28.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-07-01 至 2015-07-31
关键词:
ATP phosphohydrolaseAmyotrophic Lateral SclerosisAnimal ModelAtaxiaBiochemicalBiochemistryBiological ProcessChromatinComplexCouplingDNA Polymerase IIDNA-Directed RNA PolymeraseDiseaseElongation FactorEmployee StrikesEnzymesEventFailureFunctional RNAFunctional disorderGap JunctionsGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGenomeGoalsGuanineGuanine NucleotidesGuanosine TriphosphateHealthHumanIMP DehydrogenaseImmune System DiseasesImmunosuppressive AgentsIn VitroLearningLengthLinkMapsMessenger RNAModelingMutationNeurodegenerative DisordersNeurologicNuclearNucleotidesOrgan TransplantationOrganismOrthologous GenePharmaceutical PreparationsPhosphorylationProcessProteinsRNA Polymerase IIRNA SequencesRegulationRetinitis PigmentosaSaccharomyces cerevisiaeScanningSet proteinSignal TransductionSiteSlideStructureSystemTerminator RegionsTestingTranscriptTranscription ElongationTranscription Factor TFIIBTranscription InitiationTranscription Initiation SiteTransplant RecipientsVisualYeastsbasehelicasehuman diseasein vitro activityin vivomutantnucleasenucleotide metabolismpreventpromotersensorsmall moleculetranscription termination
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Transcription elongation and termination by RNA polymerase II are complex processes that determine the fate of the primary transcript thereby regulate gene expression. A picture is emerging in which there is more than one mode of transcription termination. This has been best examined in the yeast Saccharomyces cerevisiae. In the two conditions, different sets of proteins are involved depending upon RNA sequence signals and the primary transcript's length. In one striking example, conditional transcription termination of a non-coding RNA upstream of the IMD2 gene regulates the expression of IMP dehydrogenase, IMD2's protein product. RNA polymerase II's selection of an initiation site and TFIIB, are implicated in this process. The goal of this project is to elucidate the details of this regulatory strategy and to dissect the requirements by which RNA polymerase II chooses a termination mechanism. IMD2 serves as a useful model to understand and unravel the different mechanisms of termination. Regulation of this gene by nucleotides is seen in organisms from yeast to humans and IMP dehydrogenase is a biomedically important enzyme. Mutations in human IMPDH are linked to retinitis pigmentosa. Small molecules that inhibit it are effective drugs in wide use as valuable immunosuppressants in organ transplant recipients. This proposal will investigate the basic mechanisms of transcription initiation and termination by RNA polymerase II that allow guanine regulation of yeast IMD2. This includes the sliding search for initiation sites by pol II, the interaction of initiator and terminator regions of chromatin, the coupling of termination to exosome degradation of non-coding RNAs, and the activity of the putative helicase Sen1 in yeast and Setx in humans. The human ortholog of SEN1, SETX, is of biomedical importance since its dysfunction results in the neurodegenerative diseases Ataxia and Ocular Apraxia (AOA) type 2 and Amyotrophic Lateral Sclerosis (ALS) type 4. Unraveling this protein's biochemical and biological function will be important for understanding the pathophysiological basis of these diseases.
PUBLIC HEALTH RELEVANCE:
Project Narrative The cellular machinery that decodes (transcribes) genetic information is complex and its failure to function properly leads to a number of human diseases. This project uses a model organism in which genes, and this so-called transcription machinery, can be experimentally manipulated and will unravel the details by which genetic information is expressed. The parts of the transcription machinery studied here are involved in neurological, visual, and immunological diseases.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Elongation factor SII-dependent transcription by RNA polymerase II through a sequence-specific DNA-binding protein.
RNA 聚合酶 II 通过序列特异性 DNA 结合蛋白进行延伸因子 SII 依赖性转录。
DOI:
10.1073/pnas.90.5.1917
发表时间:
1993
期刊:
Proceedings of the National Academy of Sciences of the United States of America
影响因子:
11.1
作者:
[Reines,D, MoteJr,J]
通讯作者:
MoteJr,J
Transcription elongation by RNA polymerase II: mechanism of SII activation.
RNA 聚合酶 II 的转录延伸:SII 激活机制。
DOI:
--
发表时间:
1993
期刊:
Cellular & molecular biology research
影响因子:
--
作者:
[Reines,D, Ghanouni,P, Gu,W, MoteJr,J, Powell,W]
通讯作者:
Powell,W
Use of RNA yeast polymerase II mutants in studying transcription elongation.
使用 RNA 酵母聚合酶 II 突变体研究转录延伸。
DOI:
10.1016/s0076-6879(03)71021-0
发表时间:
2003
期刊:
Methods in enzymology
影响因子:
--
作者:
[Reines,Daniel]
通讯作者:
Reines,Daniel
Elongation factor SII contacts the 3'-end of RNA in the RNA polymerase II elongation complex.
延伸因子 SII 与 RNA 聚合酶 II 延伸复合物中 RNA 的 3 端接触。
DOI:
10.1074/jbc.271.37.22301
发表时间:
1996
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[Powell,W, Bartholomew,B, Reines,D]
通讯作者:
Reines,D
Assays for investigating transcription by RNA polymerase II in vitro.
研究 RNA 聚合酶 II 体外转录的测定。
DOI:
10.1006/meth.1997.0471
发表时间:
1997
期刊:
Methods (San Diego, Calif.)
影响因子:
--
作者:
[Reines,D, Dvir,A, Conaway,JW, Conaway,RC]
通讯作者:
Conaway,RC
共 18 条
Biochemical & Genetic Analysis of Low Complexity Domains in RNA-binding protein biology
-
批准号:9335978
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2016
-
负责人:Daniel Reines
-
依托单位:
Biochemical & Genetic Analysis of Low Complexity Domains in RNA-binding protein biology
-
批准号:9158657
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2016
-
负责人:Daniel Reines
-
依托单位:
RNA Polymerase II Elongation Complex:Structure-Function
-
批准号:7907163
-
项目类别:
-
资助金额:$8.23万
-
财政年份:2009
-
负责人:Daniel Reines
-
依托单位:
TRANSCRIPTION AND RNA BINDING IN FRAGILE X SYNDROME
-
批准号:6613926
-
项目类别:
-
资助金额:$17.25万
-
财政年份:2002
-
负责人:Daniel Reines
-
依托单位:
TRANSCRIPTION AND RNA BINDING IN FRAGILE X SYNDROME
-
批准号:6202115
-
项目类别:
-
资助金额:$17.25万
-
财政年份:1999
-
负责人:Daniel Reines
-
依托单位:
TRANSCRIPTION AND RNA BINDING IN FRAGILE X SYNDROME
-
批准号:6108901
-
项目类别:
-
资助金额:$17.25万
-
财政年份:1998
-
负责人:Daniel Reines
-
依托单位:
TRANSCRIPTION AND RNA BINDING IN FRAGILE X SYNDROME
-
批准号:6241403
-
项目类别:
-
资助金额:$17.11万
-
财政年份:1997
-
负责人:Daniel Reines
-
依托单位:
TRANSCRIPTION AND RNA BINDING IN FRAGILE X SYNDROME
-
批准号:6501527
-
项目类别:
-
资助金额:$17.25万
-
财政年份:1997
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX STRUCTURE/FUNCTION
-
批准号:2444797
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX--STRUCTURE/FUNCTION
-
批准号:6519456
-
项目类别:
-
资助金额:$26.6万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX
-
批准号:2183813
-
项目类别:
-
资助金额:$15.93万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX--STRUCTURE/FUNCTION
-
批准号:6919322
-
项目类别:
-
资助金额:$8.92万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA Polymerase II Elongation Complex:Structure-Function
-
批准号:7370986
-
项目类别:
-
资助金额:$27.09万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX STRUCTURE/FUNCTION
-
批准号:2183814
-
项目类别:
-
资助金额:$20.36万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX STRUCTURE/FUNCTION
-
批准号:2734706
-
项目类别:
-
资助金额:$21.64万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX
-
批准号:3305744
-
项目类别:
-
资助金额:$10.1万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX
-
批准号:3305742
-
项目类别:
-
资助金额:$13.32万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX--STRUCTURE/FUNCTION
-
批准号:6636034
-
项目类别:
-
资助金额:$26.6万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA POLYMERASE II ELONGATION COMPLEX STRUCTURE/FUNCTION
-
批准号:6018852
-
项目类别:
-
资助金额:$22.51万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
RNA Polymerase II Elongation Complex:Structure-Function
-
批准号:6917521
-
项目类别:
-
资助金额:$28.57万
-
财政年份:1991
-
负责人:Daniel Reines
-
依托单位:
海外基金